Summary
A twenty-six-year-old software engineer employed by a defense contractor was denied a security clearance under Guideline H (Drug Involvement). The applicant admitted to using marijuana from November 1994 through July 2000, and again from March 2001 until his arrest in February 2002 for possession of marijuana and drug paraphernalia.
Despite completing a counseling assessment and a drug education program, the judge determined there was insufficient evidence of rehabilitation. The applicant's drug involvement was not considered isolated, as he resumed use shortly after claiming abstinence.
Concerns were raised regarding the applicant's conditional intent for future drug use, which impacted his perceived reliability and trustworthiness. The judge concluded that insufficient time had passed since the applicant's last drug use and his conditional abstinence to establish the necessary trust for a security clearance, leading to the denial.
Why the Applicant Was Denied
- Applicant's drug involvement was not isolated or aberrational, as he resumed use shortly after claiming abstinence.
- The applicant's statements indicated a conditional intent regarding future drug use, raising concerns about his reliability and trustworthiness.
- Insufficient time had passed since the applicant's last drug use and his conditional abstinence to establish the necessary trust for a security clearance.
Conditions Referenced
- E2.A8.1.2.1raisedAny Drug Abuse
- E2.A8.1.2.2raisedIllegal Drug Possession
Key Rule Quoted
“Improper or illegal involvement with drugs raises questions regarding an individual's willingness or ability to protect classified information.”
Procedural Posture
- SOR issuedDec 15, 2003
- Answer filedJan 23, 2004Applicant elected to have the case decided on the written record.
- Hearing heldFeb 1, 2005
- Decision dateFeb 22, 2005
Cite For
- Conditional Intent Regarding Future Drug Use Under Guideline H
- Recent Drug Involvement and Its Impact on Security Clearance Eligibility
- The Importance of Demonstrating Rehabilitation and Trustworthiness in Drug-related Cases